Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.
Translational Research Program, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.
World J Surg Oncol. 2021 Sep 27;19(1):291. doi: 10.1186/s12957-021-02400-5.
The incidence of remnant gastric cancer (RGC) after distal gastrectomy is 1-5%. However, as the survival rate of patients with gastric cancer improves due to early detection and treatment, more patients may develop RGC. There is no consensus on the surgical and postoperative management of RGC, and the clinicopathological characteristics correlated with the long-term outcomes remain unclear. Therefore, we investigated the clinicopathological factors associated with the long-term outcomes of RGC.
We included 65 consecutive patients who underwent gastrectomy for RGC from January 2000 to December 2015 at the Osaka Medical and Pharmaceutical University Hospital, Japan. The Kaplan-Meier method was used to create survival curves, and differences in survival were compared between the groups (clinical factors, pathological factors, and surgical factors) using the log-rank test. Multivariate analyses using the Cox proportional hazard model were used to identify factors associated with long-term survival.
No significant differences were noted in the survival rate based on clinical factors (age, body mass index, diabetes mellitus, hypertension, cardiovascular disease, pulmonary complications, liver disease, diet, history of alcohol drinking, and history of smoking) or the type of remnant gastrectomy. Significant differences were noted in the survival rate based on pathological factors and surgical characteristics (intraoperative blood loss, operation time, and the number of positive lymph nodes). Multivariate analysis revealed that the T stage (hazard ratio, 5.593; 95% confidence interval [CI], 1.183-26.452; p = 0.030) and venous invasion (hazard ratio, 3.351; 95% CI, 1.030-10.903; p = 0.045) were significant independent risk factors for long-term survival in patients who underwent radical resection for RGC.
T stage and venous invasion are important prognostic factors of long-term survival after remnant gastrectomy for RGC and may be keys to managing and identifying therapeutic strategies for improving prognosis in RGC.
远端胃切除术后残胃癌(RGC)的发病率为 1-5%。然而,由于胃癌的早期发现和治疗,患者的生存率提高,更多的患者可能会发展为 RGC。对于 RGC 的手术和术后管理尚无共识,与长期结果相关的临床病理特征尚不清楚。因此,我们研究了与 RGC 长期结果相关的临床病理因素。
我们纳入了 2000 年 1 月至 2015 年 12 月在日本大阪医科药科大学医院接受胃切除术治疗 RGC 的 65 例连续患者。使用 Kaplan-Meier 方法绘制生存曲线,并使用对数秩检验比较各组(临床因素、病理因素和手术因素)之间的生存差异。使用 Cox 比例风险模型进行多变量分析,以确定与长期生存相关的因素。
在生存率方面,临床因素(年龄、体重指数、糖尿病、高血压、心血管疾病、肺部并发症、肝脏疾病、饮食、饮酒史和吸烟史)或残胃切除术类型无显著差异。在生存率方面,病理因素和手术特征(术中出血量、手术时间和阳性淋巴结数量)有显著差异。多变量分析显示,T 分期(危险比,5.593;95%置信区间 [CI],1.183-26.452;p=0.030)和静脉侵犯(危险比,3.351;95%CI,1.030-10.903;p=0.045)是 RGC 根治性切除术后长期生存的重要独立危险因素。
T 分期和静脉侵犯是 RGC 残胃切除术后长期生存的重要预后因素,可能是管理和确定改善 RGC 预后治疗策略的关键。